December 27th 2024
Emerging therapies, patient-centric medicines, and the ever-changing world of bio/pharmaceuticals complicate technology transfer.
August 19th 2024
Genentech will leverage Sangamo’s proprietary capsid delivery platform and epigenetic regulation capabilities to develop genomic medicines to address certain neurodegenerative diseases.
February 2nd 2024
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
November 15th 2023
Demand for efficient tech transfer, as well as compliant on-time delivery, is rising.
November 1st 2023
A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.